Archive for January 14th, 2010
Biocon plans clinical studies on oral insulin pill IN 105 in US
India's biotherapeutics leader Biocon Ltd is seeking approval from US FDA to conduct clinical trials for its oral insulin product code-named IN 105, reports said.
Artificial pancreas to control blood sugar levels in type 1 diabetes coming
Artificial pancreas, a fully automated system to dispense insulin to patients based on real-time changes in blood sugar levels, is currently under development.
India to conduct on-the-spot inspections on clinical trial sites from July: Reports
Indian regulatory officers will carry out random on-the-spot inspections on clinical trial sites to check deviations from July 2010.
Gardasil prevents cervical, vaginal cancers in women of 27-45 age group too: Merck
Gardasil is currently approved for use in girls and women 9 to 26 years of age
Palsy drug davunetide gets Orphan Drug Designation in US, says Allon Therapeutics
Davunetide, an investigative drug for the treatment of Progressive Supranuclear Palsy (PSP), has been granted Orphan Drug Designation by the United States Food and Drug Administration (US FDA), Allon Therapeutics Inc announced.
